144 related articles for article (PubMed ID: 7864584)
1. [11 beta-Hydroxysteroid dehydrogenase (11-beta-OHSD): physiology and lack of action in pathology].
Vantyghem MC; Hober C; Racadot A; Lefebvre J
Ann Endocrinol (Paris); 1994; 55(6):271-7. PubMed ID: 7864584
[TBL] [Abstract][Full Text] [Related]
2. Apparent mineralocorticoid excess syndromes.
Shimojo M; Stewart PM
J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
[TBL] [Abstract][Full Text] [Related]
3. Congenital and acquired syndromes of apparent mineralocorticoid excess.
Edwards CR; Walker BR; Benediktsson R; Seckl JR
J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
[TBL] [Abstract][Full Text] [Related]
4. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
5. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
6. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
Edwards CR; Stewart PM
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
[TBL] [Abstract][Full Text] [Related]
7. Apparent mineralocorticoid excess.
Benediktsson R; Edwards CR
J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
[TBL] [Abstract][Full Text] [Related]
8. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
9. Interactions between glucocorticoids and mineralocorticoids in the regulation of renal electrolyte transport.
Brem AS; Morris DJ
Mol Cell Endocrinol; 1993 Nov; 97(1-2):C1-5. PubMed ID: 8143889
[TBL] [Abstract][Full Text] [Related]
10. The specificity of the human mineralocorticoid receptor: clinical clues to a biological conundrum.
Edwards CR; Burt D; Stewart PM
J Steroid Biochem; 1989 Jan; 32(1B):213-6. PubMed ID: 2536449
[TBL] [Abstract][Full Text] [Related]
11. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P; Lovati E; Frey FJ
J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
[TBL] [Abstract][Full Text] [Related]
12. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
[TBL] [Abstract][Full Text] [Related]
13. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
Speiser PW; Riddick LM; Martin K; New MI
Metabolism; 1993 Jul; 42(7):843-5. PubMed ID: 8393954
[TBL] [Abstract][Full Text] [Related]
15. Organ-specific actions of 11 beta-hydroxysteroid dehydrogenase in humans: implications for the pathophysiology of hypertension.
Walker BR
Steroids; 1994 Feb; 59(2):84-9. PubMed ID: 8191553
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of 11 beta-hydroxysteroid dehydrogenase.
White PC; Obeid J; Agarwal AK; Tannin GM; Nikkila H
Steroids; 1994 Feb; 59(2):111-5. PubMed ID: 8191538
[TBL] [Abstract][Full Text] [Related]
19. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.
Nikkilä H; Tannin GM; New MI; Taylor NF; Kalaitzoglou G; Monder C; White PC
J Clin Endocrinol Metab; 1993 Sep; 77(3):687-91. PubMed ID: 8370690
[TBL] [Abstract][Full Text] [Related]
20. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
